Raymond James & Associates’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding BCEL
BC
BBA
GF
RG
ACM
HF
Raymond James & Associates's BCEL Position: Q4 2023 in Review
Raymond James & Associates sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q4 2023, closing a stake of 77,500 shares — an estimated $20.2K sold.
Raymond James & Associates first reported a position in BCEL in Q1 2022 and held it in 7 quarters. The position peaked at $199K in Q1 2022. 43 funds tracked by Wall St. Rank hold BCEL as of Q4 2023.
- Raymond James & Associates reported no remaining Atreca, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
- Raymond James & Associates sold 77,500 Atreca, Inc. Class A Common Stock shares in Q4 2023, an estimated $20.2K.
- Raymond James & Associates first reported a position in Atreca, Inc. Class A Common Stock in Q1 2022 and held it in 7 quarters.
- Raymond James & Associates's Atreca, Inc. Class A Common Stock position peaked at $199K in Q1 2022.
- 43 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q4 2023.
Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.